Company Overview of Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. develops and manufactures drugs for the treatment of various human disorders using its proprietary portfolio of G protein-coupled receptors. It discovers and clones genes, as well as designs G protein-coupled receptor agonists and antagonists. The company specializes in molecular biology, pharmacology, and medicinal chemistry. Lundbeck Research USA, Inc. was formerly known as Synaptic Pharmaceutical Corporation and changed its name to Lundbeck Research USA, Inc. in February 2005. The company was founded in 1987 and is based in Paramus, New Jersey. As of March 6, 2003, Lundbeck Research USA, Inc. operates as a subsidiary of H. Lundbeck A/S.
215 College Road
Paramus, NJ 07652-1431
Founded in 1987
Key Executives for Lundbeck Research USA, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Lundbeck Research USA, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.